Literature DB >> 11920817

Enterovirus meningitis in adults in 1999-2000 and evaluation of clinical management.

Hélène Peigue-Lafeuille1, Nicolas Croquez, Henri Laurichesse, Pierre Clavelou, Olivier Aumaître, Jeannot Schmidt, Marcel Maillet-Vioud, Cécile Henquell, Christine Archimbaud, Jean-Luc Bailly, Martine Chambon.   

Abstract

Enterovirus meningitis is well documented in children. However, there is a paucity of reports in adults, despite the availability of genome detection (RT-PCR) in cerebrospinal fluid (CSF), which provides a rapid and reliable diagnosis. The clinical course and management of 30 cases of entero-virus proven meningitis prospectively diagnosed between August 1999 and November 2000 in immunocompetent adults were analysed, and laboratory and clinical strategies evaluated. Patient age ranged between 17 and 43 (median 29). The analysis of clinical, biological, and epidemiological data showed the difficulty of recognising enterovirus meningitis in adults. Characteristic symptoms were either inconstant (the association of fever/headache/stiff neck) or misleading (the presence of vesicular lesions). CSF data showed moderate pleocytosis but a predominance of lymphocytes in only 12/27 (44%) patients. An epidemiological background was present in 10/30 (33%) patients, but 10/30 (33%) patients were admitted during cold months. Consequently, although the detection of enterovirus genome in CSF was positive in all cases, the results were communicated within a median of 6 days [2-9] after admission, mainly because the aetiology was not considered early enough. Management of patients varied between departments and between individual physicians, with measures ranging from computed tomography (33%) to the prescription of aciclovir (20%) or antibiotics (53%). Enterovirus meningitis should not be underestimated in adults. Management could be improved and standardised, and costs reduced by more systematic year-round use of enterovirus RT-PCR in meningitis, provided results are rapid. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920817     DOI: 10.1002/jmv.2191

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients.

Authors:  William S Mulford; Richard S Buller; Max Q Arens; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Laboratory diagnosis and genetic analysis of a family clustering outbreak of aseptic meningitis due to echovirus 30.

Authors:  Shufa Zheng; Hongyan Ye; Juying Yan; Guoliang Xie; Dawei Cui; Fei Yu; Yiyin Wang; Xianzhi Yang; Fangman Zhou; Yanjun Zhang; Xueli Tian; Yu Chen
Journal:  Pathog Glob Health       Date:  2016-09-19       Impact factor: 2.894

3.  Enterovirus meningitis in Greece from 2003-2005: diagnosis, CSF laboratory findings, and clinical manifestations.

Authors:  Kamal Dumaidi; Filanthi Frantzidou; Anna Papa; Eudoxia Diza; Antonis Antoniadis
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000.

Authors:  Christine Archimbaud; Jean-Luc Bailly; Martine Chambon; Olivier Tournilhac; Philippe Travade; Hélène Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

5.  Echovirus 30, Jiangsu Province, China.

Authors:  Yan Na Zhao; Qing Wu Jiang; Ren Jie Jiang; Liang Chen; David S Perlin
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

6.  Improvement of the management of infants, children and adults with a molecular diagnosis of Enterovirus meningitis during two observational study periods.

Authors:  Christine Archimbaud; Lemlih Ouchchane; Audrey Mirand; Martine Chambon; François Demeocq; André Labbé; Henri Laurichesse; Jeannot Schmidt; Pierre Clavelou; Olivier Aumaître; Christel Regagnon; Jean-Luc Bailly; Cécile Henquell; Hélène Peigue-Lafeuille
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.